Victhom Human Bionics Neurobionix Division receives ISO 13485:2003 Certification for its Design Control System



    QUEBEC, Jan. 23 /CNW Telbec/ - Victhom Human Bionics Inc., "Victhom"
(TSX: VHB), announced today that its Neurobionix division has achieved ISO
13485:2003 certification for its Quality System Design Control. This
certification, an internationally recognized management system standard
developed by the International Organization for Standardization (ISO),
complements the earlier certification that the Neurobionix division had
received back in August 2008 for its manufacturing activities. The combination
of both certifications guarantees that the design, development and
manufacturing functions of the Company meet the highest quality standards
known worldwide for implantable grade medical devices, including
neuromodulation systems currently being developed for commercial release late
2009.
    "This certification is an additional achievement resulting from the focus
the Company has put in the repositioning of the Neurobionix division to become
a product development engine capable of bringing innovative products to the
market at quality standards expected by the implantable medical device
industry and generally associated with larger companies", said Mr. Nader
Kameli, Chief Operating Officer of the Neurobionix division.

    About Victhom

    Victhom discovers, develops and manufactures bionic devices involved in
the treatment of a variety of physical and physiological dysfunctions.
Victhom's Neurobionix division focuses on the development and
commercialization of technologies and products involving implantable devices
that feature neurosensing and neurostimulation components, integrated with
artificial intelligence. Victhom's Biotronix division develops biomechatronic
products to support or replace peripheral limbs in what is known as the
orthotics and prosthetics market.

    Forward-Looking Statements

    Some of the statements made herein may constitute forward-looking
statements. These statements relate to future events or our future financial
performance and involve known and unknown risks, uncertainties and other
factors that may cause Victhom's actual results, performance or achievements
to be materially different from those expressed or implied by any of Victhom's
statements. Actual events or results may differ materially. We disclaim any
intention, and assume no obligation, to update these forward-looking
statements.




For further information:

For further information: Nader Kameli, Chief Operating Officer,
Neurobionix division, Victhom Human Bionics Inc., (418) 872-5665, Fax: (418)
872-6926, nader.kameli@victhom.com; www.victhom.com; Source: Victhom Human
Bionics Inc.

Organization Profile

Victhom Human Bionics Inc.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890